世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

不妊治療市場:製品毎(器具、メディア、アクセサリ)、手順毎(ART:IVF・ICSI・代理出産、人工授精、卵管結紮)、患者タイプ毎女性、男性)、エンドユーザ毎(不妊治療クリニック、病院、精子銀行) - 2023年までの世界市場予測

Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure [ART (IVF, ICSI, Surrogate), Insemination, Laparoscopy, Tubal Ligation], Patient Type (Female, Male), End User (Fertility Clinics, Hospitals, Cryobanks) - Forecasts to 2023

 

出版社 出版年月電子版価格 ページ数図表数
MarketsandMarkets
マーケッツアンドマーケッツ
2018年11月US$5,650
シングルユーザライセンス
177 138

サマリー

幅広い市場に関する調査レポートを出版しているマーケッツアンドマーケッツ(MarketsandMarkets)の不妊治療市場に関する調査レポートです。

“The infertility treatment market is projected to grow at a CAGR of 8.0% during the forecast period.”

The global infertility treatment market is projected to reach 2.2 billion by 2023 from USD 1.5 billion in 2018 at a CAGR of 8.0%. Growth in the infertility treatment market can be attributed to factors such as the declining fertility rate and rising public awareness about various infertility treatment options. However, high procedural costs and unsupportive government regulations are the major factors restricting market growth.

“The female infertility treatment segment is expected to hold the largest market share during the forecast period.”

On the basis of patient type, the global infertility treatment market has been segmented into patient infertility treatment and male infertility treatment. The female infertility treatment segment is expected to hold the largest market share during the forecast period. Factors such as decreased rate of fertility in female population and increased range of available treatment options to overcome infertility issues are driving growth in this market segment.

“The fertility centers segment is expected to grow at the highest rate during the forecast period.”

On the basis of end user, the infertility treatment market is segmented into fertility centers, hospitals & surgical clinics, cryobanks, and research institutes. The fertility centers segment is expected to grow at the highest rate during the forecast period. This is mainly due to factors such as the increasing number of fertility centers across the globe and increasing medical tourism in emerging countries.
 
“The European infertility treatment market is expected to hold the second-largest share during the forecast period.”

Geographically, the infertility treatment market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. The Europe market is expected to hold the second-largest share during the forecast period. Growth in this segment is mainly due to the declining fertility rate, growing number of fertility clinics, and increasing number of public-private investments. Moreover, increasing medical tourism in various European countries such as Spain and Italy are also shifting the focus towards the European market, thereby driving the growth of this market during the forecast period.

Breakdown of supply-side primary interviews:

- By Company Type: Tier 1 - 25%, Tier 2 - 30%, and Tier 3 - 45%
- By Designation: C-level - 26%, Director-level - 30%, and Others - 44%
- By Region: North America - 35%, Europe - 26%, APAC - 23%, and RoW - 16%

The major players in the market include The Cooper Companies Inc.  (US), Cook Group Incorporated (US), and Vitrolife AB (Sweden), Thermo Fisher Scientific, Inc. (US) Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato (Japan), Rocket Medical Plc (UK), IHMedical A/S (Denmark), Hamilton Throne Ltd. (US), MedGyn Products, Inc. (US), ZEISS Group (Germany), and SOMATEX Medical Technologies GmbH (Germany).

Research Coverage

This report studies the infertility treatment market based on product, procedure, patient type, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Key Benefits of Buying the Report

This report focuses on various levels of analysis-industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the infertility treatment market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.



目次

1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 19
1.3.1 MARKETS COVERED 19
1.3.2 GEOGRAPHIC SCOPE 20
1.3.3 YEARS CONSIDERED FOR THE STUDY 20
1.4 CURRENCY 21
1.5 STAKEHOLDERS 21

2 RESEARCH METHODOLOGY 22
2.1 RESEARCH DATA 22
2.1.1 SECONDARY DATA 24
2.1.1.1 Key data from secondary sources 24
2.1.2 PRIMARY DATA 26
2.1.2.1 Key data from primary sources 26
2.1.2.2 Breakdown of primaries 27
2.1.3 MARKET SIZE ESTIMATION 27
2.1.3.1 Product-based Market Estimation 27
2.1.4 PRIMARY RESEARCH VALIDATION 29
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 30
2.2.1 LIMITATIONS 31
2.2.2 ASSUMPTIONS FOR THE STUDY 31

3 EXECUTIVE SUMMARY  32

4 PREMIUM INSIGHTS 36
4.1 INFERTILITY TREATMENT: MARKET OVERVIEW 36
4.2 GEOGRAPHIC ANALYSIS: INFERTILITY TREATMENT MARKET,  BY PRODUCT 36
4.3 ASIA PACIFIC: INFERTILITY TREATMENT MARKET SHARE,  BY PROCEDURE (2018) 37
4.4 INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,  2018 VS. 2023 (USD MILLION) 38
4.5 INFERTILITY TREATMENT MARKET, BY END USER,  2018 VS. 2023 (USD MILLION) 39
4.6 GEOGRAPHICAL SNAPSHOT OF THE INFERTILITY TREATMENT MARKET 40
-
5 MARKET OVERVIEW 41
5.1 INTRODUCTION 41
5.2 MARKET DYNAMICS 41
5.2.1 DRIVERS 42
5.2.1.1 Declining fertility rate 42
5.2.1.2 Rising number of fertility clinics worldwide 43
5.2.1.3 Technological advancements 43
5.2.1.3.1 Advancements in infertility treatment devices 43
5.2.1.3.1 Increase in the use of time-lapse technology 44
5.2.1.4 Increasing public-private investments, funds, and grants 45
5.2.2 RESTRAINTS 45
5.2.2.1 High procedural cost of assisted reproductive techniques in developed markets 45
5.2.2.2 Unsupportive government regulations 46
5.2.3 OPPORTUNITIES 47
5.2.3.1 Growth opportunities in emerging markets 47
5.2.3.1.1 Improving healthcare infrastructure 47
5.2.3.1.2 Increasing medical tourism due to low treatment costs 47
5.2.3.2 Use of fertility treatment options by single parents and same-sex couples 48
5.2.4 CHALLENGES 49
5.2.4.1 Concerns related to ART procedures 49
5.2.4.2 Reduced efficacy among older women 50

6 INFERTILITY TREATMENT MARKET, BY PRODUCT 51
6.1 INTRODUCTION 52
6.2 EQUIPMENT 53
6.2.1 MICROSCOPES 54
6.2.1.1 Growing technological advancements in the field of microscopy resulting in the growing adoption of microscopes 54
6.2.2 IMAGING SYSTEMS 55
6.2.2.1 Emergence of time-lapse imaging systems driving the growth of the infertility treatment imaging systems market 55
6.2.3 SPERM ANALYZER SYSTEMS 56
6.2.3.1 Automated sperm analyzer systems permitting internal and external quality control and better reproducibility 56
6.2.4 OVUM ASPIRATION PUMPS 57
6.2.4.1 Ovum aspiration pumps enable smooth collection of oocytes during infertility treatment procedures 57
6.2.5 MICROMANIPULATOR SYSTEMS 57
6.2.5.1 Micromanipulators are commonly used for the treatment of male infertility, particularly cases pertaining to poor sperm quantity/mobility 57
6.2.6 INCUBATORS 59
6.2.6.1 Incubators play a vital role in embryo development and improved clinical outcomes 59
6.2.7 GAS ANALYZERS 60
6.2.7.1 Gas analyzers contain multiple ports enabling analysis  of sequential gas samples 60
6.2.8 LASER SYSTEMS 61
6.2.8.1 The common applications of laser systems include treament of stress urinary incontinence and vaginal tightening 61
6.2.9 CRYOSYSTEMS 62
6.2.9.1 Demand for cryosystems is on the rise as women are seeking to extend their childbearing years 62
6.3 MEDIA & CONSUMABLES 63
6.3.1 EASY AVAILABILITY OF CULTURE MEDIA COUPLED WITH THE GROWING AWARENESS AMONG INDIVIDUALS DRIVING THE GROWTH OF THE MEDIA & CONSUMABLES SEGMENT 63
6.4 ACCESSORIES 64
6.4.1 ANTI-VIBRATION TABLES ARE COMMONLY USED FOR IVF TREATMENTS TO PROVIDE A SMOOTH WORKSPACE DURING PROCEDURES 64

7 INFERTILITY TREATMENT MARKET, BY PROCEDURE 65
7.1 INTRODUCTION 66
7.2 ASSISTED REPRODUCTIVE TECHNOLOGY 67
7.2.1 IN VITRO FERTILIZATION 68
7.2.1.1 Intracytoplasmic morphologically selected sperm injection 69
7.2.1.1.1 IMSI is highly recommended in patients with a low sperm count and recurrent implantation failure 69
7.2.1.2 Gamete donation 69
7.2.1.2.1 Increase in the number of women registering as egg donors is a key factor aiding market growth 69
7.2.2 INTRACYTOPLASMIC SPERM INJECTION 70
7.2.2.1 ICSI is a specialized form of IVF involving fertilization used commonly in male infertility treatment procedures 70
7.2.3 SURROGACY 71
7.2.3.1 High success rates guaranteed and achieved with the help of surrogacy are driving market growth 71
7.3 ARTIFICIAL INSEMINATION 72
7.3.1 INTRAUTERINE INSEMINATION 73
7.3.1.1 Limited risk of complications during pregnancy and high success rates driving market demand for IUI procedures 73
7.3.2 INTRACERVICAL INSEMINATION 74
7.3.2.1 Low cost of procedure as compared to other AI procedures leading to increased adoption 74
7.3.3 INTRATUBAL INSEMINATION 74
7.3.3.1 Better chances of successful pregnancies using ITI to drive the demand for this procedure 74
7.4 FERTILITY SURGERY 74
7.4.1 LAPAROSCOPY 76
7.4.1.1 Laparoscopy allows for the biopsy of suspect growths and cysts that hamper fertility 76
7.4.2 HYSTEROSCOPY 76
7.4.2.1 Growing demand for minimally invasive procedures driving the adoption of hysteroscopy infertility treatment surgeries globally 76
7.4.3 MYOMECTOMY 77
7.4.3.1 Advantages of myomectomy in alleviating problems caused due to fibroids while preserving future fertility to drive the demand for this surgery 77
7.4.4 LAPAROTOMY 77
7.4.4.1 Laparotomy is used in common infertility surgeries that require large exposure to the reproductive system 77
7.4.5 TUBAL LIGATION REVERSAL 77
7.4.5.1 Tubal ligation reversal is performed only in women who still have a large portion of healthy fallopian tube remaining 77
7.4.6 VARICOCELECTOMY 78
7.4.6.1 Adoption of varicocelectomy is high among patients and results in a high chance of improved fertility with reduced complications 78
7.4.7 MICROSURGICAL RECONSTRUCTION 78
7.4.7.1 Vasovasostomy 78
7.4.7.1.1 Vasovasostomy is a reversal surgery commonly used in the treatment of infertility in men 78
7.4.7.2 Vasoepididymostomy 79
7.4.7.2.1 Vasoepididymostomy provides a higher pregnancy rate than IVF with ICSI 79
7.5 OTHER INFERTILITY TREATMENT PROCEDURES 79

8 INFERTILITY TREATMENT MARKET, BY PATIENT TYPE 80
8.1 INTRODUCTION 81
8.2 FEMALE INFERTILITY TREATMENT 82
8.2.1 INCREASING FEMALE INFERTILITY RATES TO DRIVE THE GROWTH OF THE FEMALE INFERTILITY TREATMENT MARKET 82
8.3 MALE INFERTILITY TREATMENT 83
8.3.1 GROWING ADOPTION OF MALE INFERTILITY TREATMENT PROCEDURES TO PROVIDE POTENTIAL GROWTH OPPORTUNITIES 83
-
9 INFERTILITY TREATMENT MARKET, BY END USER 84
9.1 INTRODUCTION 85
9.2 FERTILITY CENTERS 86
9.2.1 GROWING NUMBER OF INFERTILITY TREATMENT CENTERS WORLDWIDE DRIVING GROWTH OF THIS SEGMENT 86
9.3 HOSPITALS AND SURGICAL CLINICS 87
9.3.1 INITIATIVES UNDERTAKEN BY GOVERNMENTS TO INCREASE THE NUMBER OF HOSPITALS EQUIPPED TO PERFORM INFERTILITY TREATMENT PROCEDURES CONTRIBUTING TO MARKET GROWTH 87
9.4 RESEARCH INSTITUTES 88
9.4.1 GROWING NEED FOR IMPROVING THE CLINICAL EFFICACY OF VARIOUS INFERTILITY TREATMENT OPTIONS DRIVING MARKET GROWTH IN RESEARCH INSTITUTES 88
9.5 CRYOBANKS 89
9.5.1 INCREASING NUMBER OF ART PROCEDURES USING DONOR SPERM AND DONOR EGGS FOR INFERTILITY TREATMENT DRIVING THE DEMAND FOR CRYOBANKS 89

10 INFERTILITY TREATMENT MARKET, BY REGION 91
10.1 INTRODUCTION 92
10.2 NORTH AMERICA 93
10.2.1 US 97
10.2.1.1 US to dominate the infertility treatment market in North America 97
10.2.2 CANADA 99
10.2.2.1 Government initiatives and legislations for same-sex marriages to drive market growth in Canada 99
10.3 EUROPE 101
10.3.1 GERMANY 104
10.3.1.1 Favorable funding scenario for IVF treatments in Germany to drive the growth of the infertility treatment market in the country 104
10.3.2 UK 107
10.3.2.1 Increase in the number of IVF cycles in the UK contributing to market growth 107
10.3.3 FRANCE 109
10.3.3.1 The ART segment dominated the infertility treatment procedures market in France 109
10.3.4 REST OF EUROPE 111
10.4 ASIA PACIFIC 113
10.4.1 JAPAN 115
10.4.1.1 Growing awareness has served to boost the adoption of IVF procedures in Japan 115
10.4.2 CHINA 118
10.4.2.1 Declining newborn population and birth rate in China to drive the demand for infertility treatment procedures in the country 118
10.4.3 INDIA 120
10.4.3.1 Rising fertility medical tourism offering high-growth opportunities for the infertility treatment market in India 120
10.4.4 REST OF ASIA PACIFIC 122
10.5 REST OF THE WORLD 124
10.5.1 LATIN AMERICA 126
10.5.1.1 Latin America to account for the largest share of the Rest of the World infertility treatment market 126
10.5.2 MIDDLE EAST & AFRICA 128
10.5.2.1 Rising incidence of male-factor infertility to drive market growth during the forecast period 128

11 COMPETITIVE LANDSCAPE 131
11.1 OVERVIEW 131
11.2 INFERTILITY TREATMENT: MARKET SHARE ANALYSIS, 2017 131
11.3 COMPETITIVE SCENARIO 132

12 COMPANY PROFILES 135
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 COOK GROUP INCORPORATED 135
12.2 ESCO MICRO PTE. LTD. 137
12.3 GENEA LIMITED 139
12.4 HAMILTON THRONE, LTD. 141
12.5 IHMEDICAL A/S 144
12.6 IRVINE SCIENTIFIC (A MEMBER OF JX HOLDINGS GROUP) 145
12.7 IVFTECH APS 148
12.8 KITAZATO CORPORATION 149
12.9 MEDGYN PRODUCTS, INC. 151
12.10 ROCKET MEDICAL PLC 152
12.11 SOMATEX MEDICAL TECHNOLOGIES GMBH 154
12.12 THE BAKER COMPANY, INC. 155
12.13 THE COOPER COMPANIES, INC. 157
12.14 THERMO FISHER SCIENTIFIC 160
12.15 VITROLIFE AB 163
12.16 ZEISS GROUP 166
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
-
13 APPENDIX 168
13.1 DISCUSSION GUIDE 168
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 173
13.3 AVAILABLE CUSTOMIZATIONS 175
13.4 RELATED REPORTS 175
13.5 AUTHOR DETAILS 176

 

LIST OF TABLES

TABLE 1 INFERTILITY TREATMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 52
TABLE 2 INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2016-2023 (USD MILLION) 53
TABLE 3 INFERTILITY TREATMENT EQUIPMENT MARKET, BY REGION,
2016-2023 (USD MILLION) 53
TABLE 4 MICROSCOPES MARKET, BY REGION, 2016-2023 (USD MILLION) 54
TABLE 5 IMAGING SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION) 55
TABLE 6 SPERM ANALYZER SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION) 56
TABLE 7 OVUM ASPIRATION PUMPS MARKET, BY REGION, 2016-2023 (USD MILLION) 57
TABLE 8 MICROMANIPULATOR SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION) 58
TABLE 9 INCUBATORS MARKET, BY REGION, 2016-2023 (USD MILLION) 59
TABLE 10 GAS ANALYZERS MARKET, BY REGION, 2016-2023 (USD MILLION) 60
TABLE 11 LASER SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION) 61
TABLE 12 CRYOSYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION) 62
TABLE 13 MEDIA & CONSUMABLES MARKET, BY REGION, 2016-2023 (USD MILLION) 63
TABLE 14 ACCESSORIES MARKET, BY REGION, 2016-2023 (USD MILLION) 64
TABLE 15 INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2016-2023 (USD MILLION) 66
TABLE 16 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE,
2016-2023 (USD MILLION) 67
TABLE 17 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY REGION, 
2016-2023 (USD MILLION) 68
TABLE 18 IN VITRO FERTILIZATION MARKET, BY REGION, 2016-2023 (USD MILLION) 69
TABLE 19 INTRACYTOPLASMIC SPERM INJECTION MARKET, BY REGION,
2016-2023 (USD MILLION) 71
TABLE 20 SURROGACY MARKET, BY REGION, 2016-2023 (USD MILLION) 72
TABLE 21 ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2016-2023 (USD MILLION) 72
TABLE 22 ARTIFICIAL INSEMINATION MARKET, BY REGION, 2016-2023 (USD MILLION) 73
TABLE 23 FERTILITY SURGERY MARKET, BY TYPE, 2016-2023 (USD MILLION) 75
TABLE 24 FERTILITY SURGERY MARKET, BY REGION, 2016-2023 (USD MILLION) 75
TABLE 25 OTHER INFERTILITY TREATMENT PROCEDURES MARKET, BY REGION, 
2016-2023 (USD MILLION) 79
TABLE 26 INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2016-2023 (USD MILLION) 81
TABLE 27 FEMALE INFERTILITY TREATMENT MARKET, BY REGION,
2016-2023 (USD MILLION) 82
TABLE 28 MALE INFERTILITY TREATMENT MARKET, BY REGION, 2016-2023 (USD MILLION) 83
TABLE 29 INFERTILITY TREATMENT MARKET, BY END USER, 2016-2023 (USD MILLION) 85
TABLE 30 INFERTILITY TREATMENT MARKET FOR FERTILITY CLINICS, BY REGION, 
2016-2023 (USD MILLION) 86
TABLE 31 INFERTILITY TREATMENT DEVICES MARKET FOR HOSPITALS AND SURGICAL CLINICS,  BY REGION, 2016-2023 (USD MILLION) 87
TABLE 32 INFERTILITY TREATMENT MARKET FOR RESEARCH INSTITUTES, BY REGION,  2016-2023 (USD MILLION) 89
TABLE 33 INFERTILITY TREATMENT MARKET FOR CRYOBANKS, BY REGION, 
2016-2023 (USD MILLION) 90
TABLE 34 INFERTILITY TREATMENT MARKET, BY REGION, 2016-2023 (USD MILLION) 93
TABLE 35 NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 95
TABLE 36 NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 
2016-2023 (USD MILLION) 95
TABLE 37 NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY PRODUCT, 
2016-2023 (USD MILLION) 95
TABLE 38 NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 
2016-2023 (USD MILLION) 96
TABLE 39 NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY END USER, 
2016-2023 (USD MILLION) 96
TABLE 40 US: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2016-2023 (USD MILLION) 98
TABLE 41 US: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 98
TABLE 42 US: INFERTILITY TREATMENT MARKET, BY END USER, 2016-2023 (USD MILLION) 98
TABLE 43 US: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2016-2023 (USD MILLION) 99
TABLE 44 CANADA: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2016-2023 (USD MILLION) 100
TABLE 45 CANADA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2016-2023 (USD MILLION) 100
TABLE 46 CANADA: INFERTILITY TREATMENT MARKET, BY END USER,
2016-2023 (USD MILLION) 100
TABLE 47 CANADA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2016-2023 (USD MILLION) 101
TABLE 48 EUROPE: INFERTILITY TREATMENT MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 103
TABLE 49 EUROPE: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2016-2023 (USD MILLION) 103
TABLE 50 EUROPE: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2016-2023 (USD MILLION) 103
TABLE 51 EUROPE: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2016-2023 (USD MILLION) 104
TABLE 52 EUROPE: INFERTILITY TREATMENT MARKET, BY END USER,
2016-2023 (USD MILLION) 104
TABLE 53 GERMANY: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 
2016-2023 (USD MILLION) 105
TABLE 54 GERMANY: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2016-2023 (USD MILLION) 106
TABLE 55 GERMANY: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 
2016-2023 (USD MILLION) 106
TABLE 56 GERMANY: INFERTILITY TREATMENT MARKET, BY END USER,
2016-2023 (USD MILLION) 106
TABLE 57 UK: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2016-2023 (USD MILLION) 107
TABLE 58 UK: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 108
TABLE 59 UK: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2016-2023 (USD MILLION) 108
TABLE 60 UK: INFERTILITY TREATMENT MARKET, BY END USER, 2016-2023 (USD MILLION) 108
TABLE 61 FRANCE: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2016-2023 (USD MILLION) 109
TABLE 62 FRANCE: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2016-2023 (USD MILLION) 110
TABLE 63 FRANCE: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2016-2023 (USD MILLION) 110
TABLE 64 FRANCE: INFERTILITY TREATMENT MARKET, BY END USER,
2016-2023 (USD MILLION) 110
TABLE 65 ROE: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2016-2023 (USD MILLION) 111
TABLE 66 ROE: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 112
TABLE 67 ROE: INFERTILITY TREATMENT MARKET, BY END USER,
2016-2023 (USD MILLION) 112
TABLE 68 ROE: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2016-2023 (USD MILLION) 112
TABLE 69 APAC: INFERTILITY TREATMENT MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 114
TABLE 70 APAC: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2016-2023 (USD MILLION) 114
TABLE 71 APAC: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2016-2023 (USD MILLION) 114
TABLE 72 APAC: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2016-2023 (USD MILLION) 115
TABLE 73 APAC: INFERTILITY TREATMENT MARKET, BY END USER,
2016-2023 (USD MILLION) 115
TABLE 74 JAPAN: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2016-2023 (USD MILLION) 116
TABLE 75 JAPAN: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2016-2023 (USD MILLION) 116
TABLE 76 JAPAN: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2016-2023 (USD MILLION) 117
TABLE 77 JAPAN: INFERTILITY TREATMENT MARKET, BY END USER,
2016-2023 (USD MILLION) 117
TABLE 78 CHINA: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2016-2023 (USD MILLION) 118
TABLE 79 CHINA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2016-2023 (USD MILLION) 119
TABLE 80 CHINA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2016-2023 (USD MILLION) 119
TABLE 81 CHINA: INFERTILITY TREATMENT MARKET, BY END USER,
2016-2023 (USD MILLION) 119
TABLE 82 INDIA: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2016-2023 (USD MILLION) 121
TABLE 83 INDIA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2016-2023 (USD MILLION) 121
TABLE 84 INDIA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2016-2023 (USD MILLION) 121
TABLE 85 INDIA: INFERTILITY TREATMENT MARKET, BY END USER,
2016-2023 (USD MILLION) 122
TABLE 86 ROAPAC: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2016-2023 (USD MILLION) 123
TABLE 87 ROAPAC: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2016-2023 (USD MILLION) 123
TABLE 88 ROAPAC: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2016-2023 (USD MILLION) 123
TABLE 89 ROAPAC: INFERTILITY TREATMENT MARKET, BY END USER,
2016-2023 (USD MILLION) 124
TABLE 90 ROW: INFERTILITY TREATMENT MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 124
TABLE 91 ROW: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2016-2023 (USD MILLION) 125
TABLE 92 ROW: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2016-2023 (USD MILLION) 125
TABLE 93 ROW: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2016-2023 (USD MILLION) 125
TABLE 94 ROW: INFERTILITY TREATMENT MARKET, BY END USER,
2016-2023 (USD MILLION) 126
TABLE 95 LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 
2016-2023 (USD MILLION) 127
TABLE 96 LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY PRODUCT, 
2016-2023 (USD MILLION) 127
TABLE 97 LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 
2016-2023 (USD MILLION) 127
TABLE 98 LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY END USER, 
2016-2023 (USD MILLION) 128
TABLE 99 MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY PROCEDURE,  2016-2023 (USD MILLION) 129
TABLE 100 MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY PRODUCT, 
2016-2023 (USD MILLION) 129
TABLE 101 MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,  2016-2023 (USD MILLION) 129
TABLE 102 MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY END USER, 
2016-2023 (USD MILLION) 130
TABLE 103 PRODUCT LAUNCHES AND ENHANCEMENTS 132
TABLE 104 EXPANSIONS 133
TABLE 105 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS 133
TABLE 106 ACQUISITIONS 134

 

LIST OF FIGURES

FIGURE 1 INFERTILITY TREATMENT MARKET: RESEARCH METHODOLOGY STEPS 22
FIGURE 2 RESEARCH DESIGN 23
FIGURE 3 BOTTOM-UP APPROACH MARKET SIZE ESTIMATION: INFERTILITY 
TREATMENT MARKET 28
FIGURE 4 TOP-DOWN APPROACH MARKET SIZE ESTIMATION:  INFERTILITY
TREATMENT MARKET 29
FIGURE 5 DATA TRIANGULATION METHODOLOGY 30
FIGURE 6 INFERTILITY TREATMENT MARKET, BY PROCEDURE, 
2018 VS. 2023 (USD MILLION) 32
FIGURE 7 INFERTILITY TREATMENT MARKET SHARE, BY PRODUCT, 2018 33
FIGURE 8 INFERTILITY TREATMENT MARKET SHARE, BY PATIENT TYPE, 2018 33
FIGURE 9 INFERTILITY TREATMENT MARKET, BY END USER, 2018 VS. 2023 (USD MILLION) 34
FIGURE 10 GEOGRAPHIC SNAPSHOT OF THE INFERTILITY TREATMENT MARKET 35
FIGURE 11 DECLINING GLOBAL FERTILITY RATE-MAJOR FACTOR DRIVING MARKET GROWTH 36
FIGURE 12 MEDIA & CONSUMABLES MARKET IN THE ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 36
FIGURE 13 ASSISTED REPRODUCTIVE TECHNOLOGY SEGMENT TO DOMINATE THE ASIA PACIFIC INFERTILITY TREATMENT MARKET IN 2018 37
FIGURE 14 FEMALE INFERTILITY TREATMENT SEGMENT WILL CONTINUE TO DOMINATE THE INFERTILITY TREATMENT MARKET IN 2023 38
FIGURE 15 FERTILITY CENTERS TO DOMINATE THE INFERTILITY TREATMENT MARKET DURING THE FORECAST PERIOD 39
FIGURE 16 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE  FORECAST PERIOD 40
FIGURE 17 INFERTILITY TREATMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 41
FIGURE 18 DECLINING GLOBAL FERTILITY RATE (1960-2016) 42
FIGURE 19 INFERTILITY TREATMENT MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION) 52
FIGURE 20 INFERTILITY TREATMENT MARKET, BY PROCEDURE, 
2018 VS 2023 (USD MILLION) 66
FIGURE 21 FEMALE INFERTILITY TREATMENT SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 81
FIGURE 22 INFERTILITY TREATMENT MARKET, BY END USER, 2018 VS. 2023 (USD MILLION) 85
FIGURE 23 INFERTILITY TREATMENT MARKET, BY REGION, 2018 VS. 2023 (USD MILLION) 92
FIGURE 24 NORTH AMERICA: INFERTILITY TREATMENT MARKET SNAPSHOT 94
FIGURE 25 EUROPE: INFERTILITY TREATMENT MARKET SNAPSHOT 102
FIGURE 26 ASIA PACIFIC: INFERTILITY TREATMENT MARKET SNAPSHOT  113
FIGURE 27 THE COOPER COMPANIES HELD THE LEADING POSITION IN THE INFERTILITY TREATMENT MARKET, 2017 131
FIGURE 28 HAMILTON THRONE LTD.: COMPANY SNAPSHOT  141
FIGURE 29 THE COOPER COMPANIES: COMPANY SNAPSHOT  157
FIGURE 30 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 160
FIGURE 31 VITROLIFE: COMPANY SNAPSHOT 163
FIGURE 32 ZEISS GROUP: COMPANY SNAPSHOT 166

 

ページTOPに戻る

プレスリリース

[プレスリリース原文]

Infertility Treatment Market worth $2.2 billion by 2023

 

November 6, 2018

The report "Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure [ART (IVF, ICSI, Surrogate), Insemination, Laparoscopy, Tubal Ligation], Patient Type (Female, Male), End User (Fertility Clinics, Hospitals, Cryobanks) - Forecasts to 2023", The global infertility treatment market is expected to reach USD 2.2 billion by 2023 from USD 1.5 billion in 2018, at a CAGR of 8.0%. The major factors driving the growth of the infertility treatment market include declining global fertility rate; rising number of fertility clinics worldwide; technological advancements; and increasing public- private investments, funds, and grants.

The equipment segment is expected to account for the largest share of the products market in 2018

On the basis of product, the infertility treatment market is segmented into equipment, media & consumables, and accessories. The equipment segment is further categorized into incubators, micromanipulator systems, imaging & laser systems, ovum aspiration pumps, sperm analyzers, incubators, microscopes, cryosystems, and gas analyzers. The equipment segment is expected to command the largest share of the global infertility treatment market in 2018. This is primarily due to the development of new and advanced infertility treatment systems by key market players and increase in the use of these devices in IVF laboratories worldwide.

Assisted reproductive technology is expected to grow at the highest CAGR in the global infertility treatment market during the forecast period

Based on procedure, the global infertility treatment market is classified into assisted reproductive technology (ART), artificial insemination (AI), fertility surgery, and other infertility treatment procedures. The ART segment is expected to grow at the highest CAGR during the forecast period of 2018 to 2023. The large share of this segment can be attributed to ongoing technological advancements in the field of ART, growing awareness about IVF among individuals, and increasing adoption of surrogacy by single parents and same-sex couples.

Asia Pacific is expected to dominate the infertility treatment market during the forecast period

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Asia Pacific is expected to account for the largest share of the global infertility treatment market during the forecast period (2018–2023). The large share of this market can be attributed to the rise in medical tourism in Asian countries, rapid increase in healthcare expenditure, and declining fertility rates in these countries, thereby propelling the growth of the infertility treatment market in Asia Pacific.

The major players operating in the infertility treatment market include The Cooper Companies Inc.  (US), Cook Group Incorporated (US), Vitrolife AB (Sweden), Thermo Fisher Scientific, Inc. (US) Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), Irvine Scientific (US), The Baker Company, Inc. (US), and Kitazato (Japan) among others.

 

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る